ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

THMO ThermoGenesis Holdings Inc

0.63
-0.0711 (-10.14%)
Apr 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 35,801
Bid Price 0.6211
Ask Price 0.6237
News -
Day High 0.7001

Low
0.3606

52 Week Range

High
2.98

Day Low 0.600101
Company Name Stock Ticker Symbol Market Type
ThermoGenesis Holdings Inc THMO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0711 -10.14% 0.63 19:59:42
Open Price Low Price High Price Close Price Prev Close
0.6975 0.600101 0.7001 0.63 0.7011
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
190 35,801 $ 0.6534376 $ 23,394 - 0.3606 - 2.98
Last Trade Time Type Quantity Stock Price Currency
19:56:05 20 $ 0.6233 USD

ThermoGenesis Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
16.12M 3.14M - 10.48M -11.27M -3.59 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ThermoGenesis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No THMO Message Board. Create One! See More Posts on THMO Message Board See More Message Board Posts

Historical THMO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.83970.910.6001010.758483923,754-0.2097-24.97%
1 Month0.7790.96980.6001010.781220230,936-0.149-19.13%
3 Months0.40081.250.36060.782111488,9990.229257.19%
6 Months1.121.250.36060.767597481,512-0.49-43.75%
1 Year2.312.980.36061.22112,901-1.68-72.73%
3 Years110.70141.95250.360617.09651,919-110.07-99.43%
5 Years241.65638.100.360680.63662,308-241.02-99.74%

ThermoGenesis Description

ThermoGenesis Holdings Inc. develops commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking point-of-care applications and automation for immuno-oncology including its semi-automated functionally-closed CAR-TXpress platform which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.

Your Recent History

Delayed Upgrade Clock